Graduate Trainee Program- Sales

Sysmex Europe

Early Applicant

17 days ago
Be among the first 50 applicants

Exp: 0-2 Years

Full time

Saudi Arabia, Riyadh

Job Description

Are You Ready for the Challenge and Ready to Start your Career

Want to be part of a Multinational Organization
Want to explore the Business world and discover your bright future
Want to discover our Sysmex Way and how we Shape the Advancement of Healthcare

Sales Graduate Trainee Program

Sysmex LLC is proudly announcing the start of the Graduate Trainee Program which targets the Sales path. The program is designed to provide an on-Job training for a period of 12 months. The program targets Fresh local graduates with academic degrees in Laboratories, Chemistry, Biology, Microbiology, and Clinical biochemistry.

Program Features:

Paid 12 Months fast track training program.
GOSI Registration.
Paid Annual Leave.
Healthcare Insurance for the Trainee.

Location:

Riyadh, Saudi Arabia

Application:

Deadline is Nov 30, 2024.

About Sysmex LLC

Sysmex Corporation supports healthcare professionals around the world in lighting the way with diagnostics by providing a broad range of medical diagnostic products and solutions. In the fields of Haematology, urinalysis, hemostasis, life science, flow cytometry, essential healthcare and immunochemistry, we combine highly dependable, multi-functional and easy-to-operate instruments, a variety of reagents and software, plus reliable service and support.

Sysmex LLC, located in Riyadh, Saudi Arabia, is a subsidiary of the Sysmex Corporation from Kobe, Japan. From our Riyadh offices, we serve our customers in Saudi Arabia and support healthcare professionals by providing medical diagnostic products, solutions and services.

International Reputation

Sysmex ranks among the top diagnostic companies, being a world leader in haematology diagnostics and services. Globally, the company operates in more than 190 countries and regions around the world and employs more than 10,000 people.

The company's net sales at the fiscal year ended March 2022 were 2.79 billion (363.7 billion: 1=130), with the EMEA region accounting for 27.9% of that amount.